About 345 results

ALLMedicine™ Amyopathic Dermatomyositis Center

Research & Reviews  117 results

Therapeutic plasma exchange for steroid refractory idiopathic inflammatory myopathies w...
Journal of Clinical Apheresis; Thompson TZ, Bobr A et. al.

Nov 22nd, 2022 - Idiopathic inflammatory myopathies (IIMs) encompass many rheumatologic diseases characterized by inflammatory muscle disease, typically unified by proximal muscle weakness. A subset of patients with IIM present with interstitial lung disease (ILD)...

Mechanic Hands/Hiker Feet in a Patient With Amyopathic Dermatomyositis and Interstitial...
The American Journal of Dermatopathology; Regmi A, Saab-Chalhoub MW et. al.

Nov 18th, 2022 - A 30-year-old African American woman with a history of interstitial lung disease presented with bilaterally symmetrical, nonpruritic, scaling and fissuring, hyperpigmented, lichenified plaques on her hands and feet. She reported occasional erythem...

Melanoma differentiation-associated gene 5 amyopathic dermatomyositis following an acut...
Journal of Medical Case Reports; Hoey J, Solomon JL et. al.

Nov 2nd, 2022 - A previously healthy young male of Southeast Asian descent presented with 6 weeks of fevers, cough, mucocutaneous ulcers, arthritis, and myalgias. Initial workup revealed positive Mycoplasma pneumoniae immunoglobulin M, and the patient was treated...

A case of clinically amyopathic dermatomyositis in a Filipino woman.
International Journal of Rheumatic Diseases; Amadore RA, Bangayan RJ et. al.

Oct 3rd, 2022 - This is a case of a 59-year-old woman who presented with a 2-year history of heliotrope rash, Gottron's papules, shawl sign, V-neck sign, and muscle weakness. She was previously managed as a case of systemic lupus erythematosus and initially respo...

Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyo...
Arthritis & Rheumatology (Hoboken, N.J.); Ye Y, Zhang X et. al.

Jun 18th, 2022 - Amyopathic dermatomyositis (ADM) is a heterogeneous and life-threatening autoimmune disease with a high mortality rate. In particular, anti-melanoma differentiation-associated protein 5 antibody-positive patients are at a high risk of developing r...

see more →

Clinicaltrials.gov  5 results

Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis

Sep 16th, 2021 - Adult and juvenile dermatomyositis (DM) are systemic immune-mediated inflammatory diseases most commonly affecting the skin and musculoskeletal system. Amyopathic dermatomyositis is a subtype of dermatomyositis that affects only the skin and lacks...

The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients

Jul 19th, 2021 - Dermatomyositis (DM) is an idiopathic inflammatory myopathy characterized by chronic inflammation in the skin and muscle. Anti-melanoma differentiation-associated gene5 (Anti-MDA5) antibody positive DM is a subtype of DM that is more frequent in E...

Correlation Between the Change of Peripheral Lymphocyte Subsets and Clinically Amyopathic Dermatomyositis Combined With Rapidly Progressive Interstitial Lung Disease

Nov 3rd, 2020 - Acute respiratory distress syndrome (ARDS) occurs in Clinically Amyopathic Dermatomyisitis(CADM) combined with Rapidly Progressive Interstitial Lung Disease(RPILD) within 1-3 months, which leads to death of patients and is difficult to treat. Even...

Basiliximab Treating Interstitial Pneumonia of CADM

Jun 20th, 2017 - This is a 52-week, randomized, open and routine treatment controlled study. This study will assess the safety and efficacy of basiliximab as an add-on treatment for interstitial pneumonia in clinical amyopathic dermatomyositis (CADM) patients. 100...

Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis

Jul 1st, 2016 - Interstitial lung disease (ILD) is a common complication of dermatomyositis (DM) with prevalence up to 65%, and is considered to be one of the determining factors of prognosis. Clinical amyopathic dermatomyositis (CADM), which is a special phenoty...

see more →

News  16 results

First Recommendations for Cancer Screening in Myositis Issued

Nov 12th, 2022 - PHILADELPHIA – The first consensus screening guidelines for patients with idiopathic inflammatory myopathy (IIM) provide recommendations on risk stratification for individuals, basic and enhanced screening protocols, and screening frequency. Alexa...

Validity of commercial serologic tests for dermatomyositis still questionable
Doug Brunk

Nov 24th, 2021 - Clinical assessment for pulmonary disease and malignancy in patients with dermatomyositis should not be replaced with serologic tests at this time, according to Jeffrey P. Callen, MD.

Papules and Telangiectases on the Distal Fingers of a Child
Briana Brown, DO, Jacqueline Jones, DO et. al.

Apr 8th, 2019 - The Diagnosis: Juvenile Dermatomyositis Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory myopathy of childhood that is autoimmune in nature with an annual incidence ranging from 2. 5 to 4.

Papules and Telangiectases on the Distal Fingers of a Child
Briana Brown, DO, Jacqueline Jones, DO et. al.

Apr 8th, 2019 - The Diagnosis: Juvenile Dermatomyositis Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory myopathy of childhood that is autoimmune in nature with an annual incidence ranging from 2. 5 to 4.

Timely dermatomyositis diagnosis, treatment remain elusive

Jun 3rd, 2018 - “We saw that there was a much higher rate of misdiagnosis in patients who didn’t have any muscle disease. We have to raise awareness that amyopathic dermatomyositis is a very prevalent condition,” Dr.

see more →